News
The agreement between BioNTech’s subsidiary BioNTech UK and the UK government is focused on accelerating clinical trials for ...
Olaparib tablets, marketed under the brand name Lynparza, are already available on the NHS for certain breast cancer ...
The struggle to make clinical trials easier to conduct and more attractive to patients while understanding the impact of ...
Science communication, together with creativity, ensures that information is both accurate and accessible. In order to ...
Medscape Oncology is making a powerful impact at ASCO 2025, bringing seven high-impact symposia, new research insights, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results